figshare
Browse
sj-docx-1-vrd-10.1177_2474126421989225.docx (419.62 kB)

Supplemental Material, sj-docx-1-vrd-10.1177_2474126421989225 - Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion

Download (419.62 kB)
journal contribution
posted on 2021-03-02, 01:06 authored by Yasha S. Modi, Lediana Goduni, Hadi Moini, Andrea Gibson, Nick Boucher, Genevieve Lucas, Dilsher S. Dhoot

Supplemental Material, sj-docx-1-vrd-10.1177_2474126421989225 for Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion by Yasha S. Modi, Lediana Goduni, Hadi Moini, Andrea Gibson, Nick Boucher, Genevieve Lucas and Dilsher S. Dhoot in Journal of VitreoRetinal Diseases

Funding

Regeneron Pharmaceuticals, Inc.

History

Usage metrics

    Journal of VitreoRetinal Diseases

    Categories

    Keywords

    antivascular endothelial growth factorbevacizumabcentral retinal vein occlusionintravitreal afliberceptranibizumabreal-world outcomestreatment frequencyvisual acuity

    Licence

    In Copyright

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC